Wednesday, September 25, 2019
- 1:15pm-2:45pm
 - 
					
Functional connectome in Parkinson’s disease mild cognitive impairment
Neuroimaging · Les Muses Terrace, Level 3 
- 1:15pm-2:45pm
 - 
					
Functional magnetic-resonant imaging in child cerebral palsy with epilepsy
Neuroimaging · Les Muses Terrace, Level 3 
- 1:15pm-2:45pm
 - 
					
Functional MRI activation during the Symbol Digit Modalities Test in Parkinson’s disease
Neuroimaging · Les Muses Terrace, Level 3 
- 1:15pm-2:45pm
 - 
					
Functional Proteomic Analysis of Leukocytes from Parkinson’s Disease Patients: A Clinical Perspective on Biomarkers Identification
Physiology and Pathophysiology · Les Muses, Level 3 
- 1:15pm-2:45pm
 - 
					
Gait patterns may distinguish Parkinsonian patients with and without mild cognitive impairment: a data mining approach
Cognition and Cognitive Disorders · Agora 3 East, Level 3 
- 1:15pm-2:45pm
 - 
					
Gamma-glutamyltransferase and the risk of Parkinson’s disease: A National Health Service big data analysis
Epidemiology · Les Muses, Level 3 
- 1:15pm-2:45pm
 - 
					
Gastrointestinal disorders in various forms of parkinsonism
Non-Motor Symptoms · Agora 3 West, Level 3 
- 1:15pm-2:45pm
 - 
					
Gastrointestinal microbiome in Parkinson’s disease in a Bavarian cohort
Non-Motor Symptoms · Agora 3 West, Level 3 
- 1:15pm-2:45pm
 - 
					
Gastrointestinal symptoms as a risk factor for the appearance of motor fluctuations in patients with advanced Parkinson disease
Phenomenology and Clinical Assessment of Movement Disorders · Les Muses Terrace, Level 3 
- 1:15pm-2:45pm
 - 
					
Gastrointestinal symptoms predict cognitive decline in Parkinson’s Disease
Non-Motor Symptoms · Agora 3 West, Level 3 
- «Previous Page
 - 1
 - …
 - 25
 - 26
 - 27
 - 28
 - 29
 - …
 - 67
 - Next Page»
 
